These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 3892050

  • 1. Bacillus Calmette-Guerin immunotherapy for bladder cancer.
    Lamm DL.
    J Urol; 1985 Jul; 134(1):40-7. PubMed ID: 3892050
    [Abstract] [Full Text] [Related]

  • 2. Bladder cancer immunotherapy.
    Lamm DL, Thor DE, Stogdill VD, Radwin HM.
    J Urol; 1982 Nov; 128(5):931-5. PubMed ID: 6757467
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Results of 6 weekly intravesical bacillus Calmette-Guerin instillations on the treatment of superficial bladder tumors.
    Kavoussi LR, Torrence RJ, Gillen DP, Hudson MA, Haaff EO, Dresner SM, Ratliff TL, Catalona WJ.
    J Urol; 1988 May; 139(5):935-40. PubMed ID: 3361667
    [Abstract] [Full Text] [Related]

  • 9. The management of superficial bladder tumors and carcinoma in situ with intravesical bacillus Calmette-Guerin.
    deKernion JB, Huang MY, Lindner A, Smith RB, Kaufman JJ.
    J Urol; 1985 Apr; 133(4):598-601. PubMed ID: 3981707
    [Abstract] [Full Text] [Related]

  • 10. Long-term results of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer.
    Sarosdy MF, Lamm DL.
    J Urol; 1989 Sep; 142(3):719-22. PubMed ID: 2769847
    [Abstract] [Full Text] [Related]

  • 11. Long-term followup of patients treated with 1 or 2, 6-week courses of intravesical bacillus Calmette-Guerin: analysis of possible predictors of response free of tumor.
    Coplen DE, Marcus MD, Myers JA, Ratliff TL, Catalona WJ.
    J Urol; 1990 Sep; 144(3):652-7. PubMed ID: 2388321
    [Abstract] [Full Text] [Related]

  • 12. Long term protection in bladder cancer following intralesional immunotherapy.
    Reichert DF, Lamm DL.
    J Urol; 1984 Sep; 132(3):570-3. PubMed ID: 6381762
    [Abstract] [Full Text] [Related]

  • 13. The use of bacillus Calmette-Guerin in the therapy of bladder carcinoma in situ.
    Brosman SA.
    J Urol; 1985 Jul; 134(1):36-9. PubMed ID: 3892049
    [Abstract] [Full Text] [Related]

  • 14. Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer.
    Martínez-Piñeiro JA, Jiménez León J, Martínez-Piñeiro L, Fiter L, Mosteiro JA, Navarro J, García Matres MJ, Cárcamo P.
    J Urol; 1990 Mar; 143(3):502-6. PubMed ID: 2106041
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression.
    Herr HW, Badalament RA, Amato DA, Laudone VP, Fair WR, Whitmore WF.
    J Urol; 1989 Jan; 141(1):22-9. PubMed ID: 2908949
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bacillus Calmette-Guerin immunotherapy of infiltrating bladder cancer.
    Netto NR, Lemos GC.
    J Urol; 1984 Oct; 132(4):675-7. PubMed ID: 6471211
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.